Renhuang Pharmaceuticals, Inc. (“Renhuang” or the “Company”, stock symbol: RHGP.OB), a leading Chinese integrated drug developer, manufacturer and distributor, announced the successful laboratory production of lyophilized syringin powder, its new powder injection anti-depression and fatigue drug. Renhuang expects this new drug to become its next revenue growth driver. At 90% purity, the syringin portion in the sample drugs meets the criteria of the State Food and Drug Administration (SFDA).
Popularity: unranked [?]
